SOX2 and colorectal carcinoma: A recent study by Zhu et al. demonstrated a novel mechanism by which the SOX2/β-catenin/Beclin1/autophagy signaling axis regulates chemoresistance, stemness, and EMT in colorectal cancer (CRC) [177].